• Edwards Lifesciences Corp EW.N reported quarterly adjusted earnings of 64 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 66 cents. The mean expectation of twenty seven analysts for the quarter was for earnings of 60 cents per share. Wall Street expected results to range from 57 cents to 64 cents per share.

• Revenue fell 11.6% to $1.41 billion from a year ago; analysts expected $1.40 billion.

• Edwards Lifesciences Corp's reported EPS for the quarter was 61 cents​.

• The company reported quarterly net income of $358 million.

• Edwards Lifesciences Corp shares had fallen by 2.6% this quarter and lost 4.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.8% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 17 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Edwards Lifesciences Corp is $80.00

This summary was machine generated from LSEG data April 23 at 10:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)